Abstract
In this study, the influence of copolymer composition on drug–polymer solubility was investigated. The solubility of the model drug celecoxib (CCX) in various polyvinylpyrrolidone/vinyl acetate (PVP/VA) copolymer compositions (70/30, 60/40, 50/50 and 30/70 w/w) and the pure homopolymers polyvinylpyrrolidone (PVP) and polyvinyl acetate (PVA) was predicted at 25 °C using a thermal analysis method based on the recrystallization of a supersaturated amorphous dispersion (recrystallization method). These solubilities were compared with a prediction based on the solubility of CCX in the liquid monomeric precursors of PVP/VA, N-vinylpyrrolidone (NVP) and vinyl acetate (VA), using the Flory–Huggins lattice theory (liquid monomer solubility approach).
The solubilities predicted from the liquid monomer solubility approach increased linearly with increasing VP/VA ratio from 0.03–0.60 w/w. Even though the solubilities predicted from the recrystallization method also increased with increasing VP/VA ratio from 0.02–0.40 w/w, the predicted solubility seemed to approach a plateau at high VP/VA ratios.
Increasing positive deviations from the Gordon–Taylor equation with increasing VP/VA ratio indicated strong interactions between CCX and the VP repeat unit, which was in accordance with the relatively high solubilities predicted using both methods.
As the solubility plateau may be a consequence of steric hindrance caused by the size differences between CCX and the VP repeat units, it is likely that a CCX molecule interacting with a VP repeat unit hinders another CCX molecule from binding to the neighboring repeat units in the polymer chain.
Therefore, it is possible that replacing these neighboring hygroscopic VP repeat units with hydrophobic VA repeat units, could increase the physical stability of an amorphous solid dispersion without compromising the drug–polymer solubility. This knowledge could be used advantageously in future development of amorphous drug delivery systems as copolymers could be customized to provide optimal drug–polymer solubility and physical stability.
The solubilities predicted from the liquid monomer solubility approach increased linearly with increasing VP/VA ratio from 0.03–0.60 w/w. Even though the solubilities predicted from the recrystallization method also increased with increasing VP/VA ratio from 0.02–0.40 w/w, the predicted solubility seemed to approach a plateau at high VP/VA ratios.
Increasing positive deviations from the Gordon–Taylor equation with increasing VP/VA ratio indicated strong interactions between CCX and the VP repeat unit, which was in accordance with the relatively high solubilities predicted using both methods.
As the solubility plateau may be a consequence of steric hindrance caused by the size differences between CCX and the VP repeat units, it is likely that a CCX molecule interacting with a VP repeat unit hinders another CCX molecule from binding to the neighboring repeat units in the polymer chain.
Therefore, it is possible that replacing these neighboring hygroscopic VP repeat units with hydrophobic VA repeat units, could increase the physical stability of an amorphous solid dispersion without compromising the drug–polymer solubility. This knowledge could be used advantageously in future development of amorphous drug delivery systems as copolymers could be customized to provide optimal drug–polymer solubility and physical stability.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Journal of Pharmaceutical Sciences |
| Vol/bind | 85 |
| Sider (fra-til) | 10-17 |
| Antal sider | 8 |
| ISSN | 0928-0987 |
| DOI | |
| Status | Udgivet - 31 mar. 2016 |